ARCHIVES

FDA Officials Lists ‘Lessons’ Learned Working With AIDS Patient Organizations

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays New Program Projects For Diagnosis Research

June 7, 1985

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted

September 6, 1974

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

DCT Board Oks Limited Support For Development Of Neutron Therapy

March 31, 1978